{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:56:41Z","timestamp":1792083401380,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34788-5","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T19:43:08Z","timestamp":1767728588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Occult hepatitis B virus infection among hepatitis B surface antigen negative vaccinated healthcare workers in East Gojjam zone hospitals"],"prefix":"10.1038","volume":"16","author":[{"given":"Adane","family":"Adugna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn","family":"Abebaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabarak","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"34788_CR1","doi-asserted-by":"crossref","unstructured":"Zobeiri, M. Occult hepatitis B: clinical viewpoint and management. Hepatitis research and treatment 2013:259148. (2013).","DOI":"10.1155\/2013\/259148"},{"key":"34788_CR2","doi-asserted-by":"crossref","unstructured":"Li, T., Fu, Y., Allain, J-P. & Li, C. Chronic and occult hepatitis B virus infections in the vaccinated Chinese population. Annals Blood 2(3), 1\u201311 (2017).","DOI":"10.21037\/aob.2017.04.02"},{"issue":"39","key":"34788_CR3","doi-asserted-by":"publisher","first-page":"8720","DOI":"10.3748\/wjg.v22.i39.8720","volume":"22","author":"M Makvandi","year":"2016","unstructured":"Makvandi, M. Update on occult hepatitis B virus infection. World J. Gastroenterol. 22 (39), 8720\u20138734 (2016).","journal-title":"World J. Gastroenterol."},{"key":"34788_CR4","unstructured":"Sansure: https:\/\/www.sansureglobal.com\/global-prevalence-of-occult-hepatitis-b-a-systematic-review-and-meta-analysis, accessed on 8\/24\/2025."},{"issue":"5","key":"34788_CR5","first-page":"862","volume":"226","author":"G Ndow","year":"2022","unstructured":"Ndow, G., Cessay, A., Cohen, D. & Shimakawa, Y. Prevalence and clinical significance of occult hepatitis B infection in the Gambia. West. Afr. 226 (5), 862\u2013870 (2022).","journal-title":"West. Afr."},{"issue":"1","key":"34788_CR6","doi-asserted-by":"publisher","first-page":"13188","DOI":"10.1038\/s41598-022-17336-3","volume":"12","author":"SB Gissa","year":"2022","unstructured":"Gissa, S. B. et al. Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, addis Ababa Ethiopia. Sci. Rep. 12 (1), 13188 (2022).","journal-title":"Sci. Rep."},{"issue":"12","key":"34788_CR7","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","volume":"2","author":"CW Spearman","year":"2017","unstructured":"Spearman, C. W. et al. Hepatitis B in sub-Saharan africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol. Hepatol. 2 (12), 900\u2013909 (2017).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"34788_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/v14010082","volume":"14","author":"MW Sonderup","year":"2022","unstructured":"Sonderup, M. W. & Spearman, C. W. Global disparities in hepatitis B elimination\u2014a focus on Africa. Viruses 14 (1), 82 (2022).","journal-title":"Viruses"},{"key":"34788_CR9","doi-asserted-by":"crossref","unstructured":"Saitta, C., Pollicino, T. & Raimondo, G. Occult hepatitis B virus infection: an update. Viruses 14 (7), (2022).","DOI":"10.3390\/v14071504"},{"key":"34788_CR10","doi-asserted-by":"publisher","first-page":"111448","DOI":"10.1016\/j.bios.2019.111448","volume":"141","author":"SH Lee","year":"2019","unstructured":"Lee, S. H. et al. Emerging ultrafast nucleic acid amplification technologies for next-generation molecular diagnostics. Biosens. Bioelectron. 141, 111448 (2019).","journal-title":"Biosens. Bioelectron."},{"key":"34788_CR11","doi-asserted-by":"publisher","first-page":"118172","DOI":"10.1016\/j.trac.2025.118172","volume":"185","author":"S De Silva","year":"2025","unstructured":"De Silva, S., Lee, S-S., Dugan, M. B. & Anderson, J. L. Recent advancements and emerging techniques in nucleic acid isolation, amplification, and detection from diverse complex matrices of human interest. TRAC Trends Anal. Chem. 185, 118172 (2025).","journal-title":"TRAC Trends Anal. Chem."},{"key":"34788_CR12","doi-asserted-by":"publisher","first-page":"1186877","DOI":"10.3389\/fcimb.2023.1186877","volume":"13","author":"C Wang","year":"2023","unstructured":"Wang, C., Xue, R., Wang, X., Xiao, L. & Xian, J. High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable. Front. Cell. Infect. Microbiol. 13, 1186877 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"34788_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12985-025-02712-y","volume":"22","author":"Y Wu","year":"2025","unstructured":"Wu, Y. et al. Serum hepatitis B virus RNA in low-level viremia of chronic hepatitis B: clinical features and association with virological response. Virol. J. 22 (1), 132 (2025).","journal-title":"Virol. J."},{"key":"34788_CR14","unstructured":"Zhang, Q. et al. Chronic hepatitis B infection with low level viremia correlates with the progression of the liver disease. J. Clin. Transl. Hepatol. 9 (6), 850\u2013859 (2021)."},{"issue":"8","key":"34788_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3748\/wjg.v27.i8.666","volume":"27","author":"GQ Yin","year":"2021","unstructured":"Yin, G. Q., Li, J., Zhong, B., Yang, Y. F. & Wang, M. R. New therapeutic options for persistent low-level viremia in patients with chronic hepatitis B virus infection: increase of Entecavir dosage. World J. Gastroenterol. 27 (8), 666\u2013676 (2021).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"34788_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-anchem-061622-015112","volume":"17","author":"JC Rolando","year":"2024","unstructured":"Rolando, J. C., Melkonian, A. V. & Walt, D. R. The present and future landscapes of molecular diagnostics. Annual Rev. Anal. Chem. (Palo Alto Calif). 17 (1), 459\u2013474 (2024).","journal-title":"Annual Rev. Anal. Chem. (Palo Alto Calif)"},{"issue":"2","key":"34788_CR17","first-page":"227","volume":"13","author":"S Arora","year":"2015","unstructured":"Arora, S., Doda, V. & Kirtania, T. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples. Blood Transfus. = Trasfusione del. Sangue. 13 (2), 227\u2013232 (2015).","journal-title":"Blood Transfus. = Trasfusione del. Sangue"},{"key":"34788_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijid.2014.04.007","volume":"25","author":"G Albertoni","year":"2014","unstructured":"Albertoni, G., Castelo Gir\u00e3o, M. J. B. & Schor, N. Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. Int. J. Infect. Dis. 25, 145\u2013149 (2014).","journal-title":"Int. J. Infect. Dis."},{"issue":"17","key":"34788_CR19","doi-asserted-by":"publisher","first-page":"e37097","DOI":"10.1016\/j.heliyon.2024.e37097","volume":"10","author":"S Delghandi","year":"2024","unstructured":"Delghandi, S. et al. An overview of occult hepatitis B infection (OBI) with emphasis on HBV vaccination. Heliyon 10 (17), e37097 (2024).","journal-title":"Heliyon"},{"issue":"4","key":"34788_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/diagnostics15040486","volume":"15","author":"AS Alshrari","year":"2025","unstructured":"Alshrari, A. S. et al. Prevalence and transfusion risks of occult hepatitis B infection among HBcAb-positive blood donors in a high-endemic region. Diagnostics 15 (4), 486 (2025).","journal-title":"Diagnostics"},{"issue":"1","key":"34788_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42506-023-00138-4","volume":"98","author":"A Azzam","year":"2023","unstructured":"Azzam, A., Khaled, H., El-Kayal, E. S., Gad, F. A. & Omar, S. Prevalence of occult hepatitis B virus infection in egypt: a systematic review with meta-analysis. J. Egypt. Public Health Assoc. 98 (1), 13 (2023).","journal-title":"J. Egypt. Public Health Assoc."},{"issue":"11","key":"34788_CR22","doi-asserted-by":"publisher","first-page":"e0242577","DOI":"10.1371\/journal.pone.0242577","volume":"15","author":"NH Patel","year":"2020","unstructured":"Patel, N. H. et al. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia. PloS One. 15 (11), e0242577 (2020).","journal-title":"PloS One"},{"issue":"3","key":"34788_CR23","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/jam.15351","volume":"132","author":"NAA de Almeida","year":"2022","unstructured":"de Almeida, N. A. A. & de Paula, V. S. Occult hepatitis B virus (HBV) infection and challenges for hepatitis elimination: A literature review. J. Appl. Microbiol. 132 (3), 1616\u20131635 (2022).","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"34788_CR24","first-page":"1","volume":"4","author":"M-F Yuen","year":"2018","unstructured":"Yuen, M-F. et al. Hepatitis B virus infection. Nat. Reviews Disease Primers. 4 (1), 1\u201320 (2018).","journal-title":"Nat. Reviews Disease Primers"},{"key":"34788_CR25","doi-asserted-by":"crossref","unstructured":"Mengistu, D. A. & Dirirsa, G. Global Occupational Exposure to Blood and Body Fluids among Healthcare Workers: Systematic Review and Meta-Analysis. 2022:5732046. (2022).","DOI":"10.1155\/2022\/5732046"},{"key":"34788_CR26","unstructured":"CDC. https:\/\/www.cdc.gov\/niosh\/healthcare\/risk-factors\/index.html, accessed on 8\/20\/2025."},{"key":"34788_CR27","doi-asserted-by":"crossref","unstructured":"Lee, D. I. & Nande, A. Vaccine failure mode determines population-level impact of vaccination campaigns during epidemics. J. R. Soc. Interface 22 (223), 20240689 (2025).","DOI":"10.1098\/rsif.2024.0689"},{"issue":"1","key":"34788_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14760584.2024.2331065","volume":"23","author":"VM Vashishtha","year":"2024","unstructured":"Vashishtha, V. M. & Kumar, P. The durability of vaccine-induced protection: an overview. Expert Rev. Vaccines. 23 (1), 389\u2013408 (2024).","journal-title":"Expert Rev. Vaccines"},{"issue":"7","key":"34788_CR29","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/v14071504","volume":"14","author":"C Saitta","year":"2022","unstructured":"Saitta, C., Pollicino, T. & Raimondo, G. Occult hepatitis B virus infection: an update. Viruses 14 (7), 1504 (2022).","journal-title":"Viruses"},{"issue":"10","key":"34788_CR30","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S2468-1253(22)00201-1","volume":"7","author":"YR Im","year":"2022","unstructured":"Im, Y. R. et al. Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7 (10), 932\u2013942 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"34788_CR31","doi-asserted-by":"crossref","unstructured":"Teshome, S. et al. Antibody response against hepatitis B virus after vaccination and Seroprevalence of HBV in children in addis Ababa, Ethiopia. Ethiopian Med. Journal (2019).","DOI":"10.1016\/j.cca.2019.03.1167"},{"issue":"33","key":"34788_CR32","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1016\/j.vaccine.2016.05.040","volume":"34","author":"TH Sondlane","year":"2016","unstructured":"Sondlane, T. H. et al. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa. Vaccine 34 (33), 3835\u20133839 (2016).","journal-title":"Vaccine"},{"issue":"6","key":"34788_CR33","doi-asserted-by":"publisher","first-page":"e088756","DOI":"10.1136\/bmjopen-2024-088756","volume":"15","author":"L Xie","year":"2025","unstructured":"Xie, L., Liu, G., Liu, Y., Li, P. & Guo, H. Prevalence of low-level viremia in the treatment of chronic hepatitis B in china: a systematic review and meta-analysis. BMJ open. 15 (6), e088756 (2025).","journal-title":"BMJ open."},{"key":"34788_CR34","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhang, Y. & Zhu, L. Non-Invasive monitoring of the impact of Low-Level viremia on liver fibrosis in treated chronic hepatitis B patients. J. Clin. Transl. Hepatol. 17, 2751\u20132758 (2024).","DOI":"10.2147\/IDR.S463843"},{"key":"34788_CR35","doi-asserted-by":"crossref","unstructured":"Kim, G. A., Han, S., Choi, G. H., Choi, J. & Lim, Y. S. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients. Gastroenterology 51 (11), 1169\u20131179 (2020).","DOI":"10.1111\/apt.15725"},{"key":"34788_CR36","doi-asserted-by":"publisher","first-page":"1151899","DOI":"10.3389\/fcimb.2023.1151899","volume":"13","author":"J Li","year":"2023","unstructured":"Li, J. et al. Factors associated with persistent positive in HBV DNA level in patients with chronic hepatitis B receiving Entecavir treatment. Front. Cell. Infect. Microbiol. 13, 1151899 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"34788_CR37","first-page":"e0242577","volume":"15","author":"NH Patel","year":"2020","unstructured":"Patel, N. H. & Meier-Stephenson, V. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar. Ethiopia 15 (11), e0242577 (2020).","journal-title":"Ethiopia"},{"key":"34788_CR38","doi-asserted-by":"publisher","first-page":"887260","DOI":"10.3389\/fgstr.2022.887260","volume":"1","author":"G Gemechu","year":"2022","unstructured":"Gemechu, G. et al. Occult hepatitis B virus infection among blood donors in the capital City of addis Ababa, ethiopia: implications for blood transfusion safety. Front. Gastroenterol. 1, 887260 (2022).","journal-title":"Front. Gastroenterol."},{"key":"34788_CR39","doi-asserted-by":"crossref","unstructured":"Zhong, G. et al. Increasing prevalence of occult HBV infection in adults vaccinated against hepatitis B at birth. Ann. Blood 13 (2), (2025).","DOI":"10.3390\/vaccines13020174"},{"key":"34788_CR40","doi-asserted-by":"crossref","unstructured":"Ingasia, L. A. O., Kostaki, E. G., Paraskevis, D. & Kramvis, A. Global and regional dispersal patterns of hepatitis B virus genotype E from and in africa: A full-genome molecular analysis. PLoS Negl. Trop. Dis. 15(10), e0240375 (2020).","DOI":"10.1371\/journal.pone.0240375"},{"key":"34788_CR41","doi-asserted-by":"crossref","unstructured":"Kumar, M., Pahuja, S., Khare, P. & Kumar, A. Current Challenges and Future Perspectives of Diagnosis of Hepatitis B Virus. 13(3), (2023).","DOI":"10.3390\/diagnostics13030368"},{"issue":"1","key":"34788_CR42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12879-017-2776-z","volume":"17","author":"B Lange","year":"2017","unstructured":"Lange, B. et al. Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples \u2013 a systematic review and meta-analysis. BMC Infect. Dis. 17 (1), 693 (2017).","journal-title":"BMC Infect. Dis."},{"key":"34788_CR43","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Thompson, A. J. & Howell, J. Point-of-Care tests for hepatitis B: an overview. Cells 9(10), (2020).","DOI":"10.3390\/cells9102233"},{"issue":"30","key":"34788_CR44","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3748\/wjg.v24.i30.3347","volume":"24","author":"IM Akcay","year":"2018","unstructured":"Akcay, I. M., Katrinli, S., Ozdil, K., Doganay, G. D. & Doganay, L. Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies. World J. Gastroenterol. 24 (30), 3347\u20133360 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"34788_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1590\/s1806-37562018000000088","volume":"44","author":"CM Patino","year":"2018","unstructured":"Patino, C. M. & Ferreira, J. C. Inclusion and exclusion criteria in research studies: definitions and why they matter. Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia. 44 (2), 84 (2018).","journal-title":"Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia"},{"key":"34788_CR46","doi-asserted-by":"publisher","first-page":"100662","DOI":"10.1016\/j.oor.2024.100662","volume":"12","author":"SK Ahmed","year":"2024","unstructured":"Ahmed, S. K. How to choose a sampling technique and determine sample size for research: A simplified guide for researchers. Oral Oncol. Rep. 12, 100662 (2024).","journal-title":"Oral Oncol. Rep."},{"key":"34788_CR47","doi-asserted-by":"crossref","unstructured":"Bello, N. & Hudu, S. A. Overview of hepatitis B vaccine Non-Response and associated B cell amnesia: A scoping review. Pathogens 13(7), (2024).","DOI":"10.3390\/pathogens13070554"},{"issue":"3","key":"34788_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.anai.2018.03.017","volume":"121","author":"TV Saco","year":"2018","unstructured":"Saco, T. V., Strauss, A. T. & Ledford, D. K. Hepatitis B vaccine nonresponders: possible mechanisms and solutions. Ann. Allergy Asthma Immunol. 121 (3), 320\u2013327 (2018).","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"34788_CR49","doi-asserted-by":"publisher","first-page":"e0262126","DOI":"10.1371\/journal.pone.0262126","volume":"17","author":"M Ocan","year":"2022","unstructured":"Ocan, M. et al. Antibody levels and protection after hepatitis B vaccine in adult vaccinated healthcare workers in Northern Uganda. PloS One. 17 (1), e0262126 (2022).","journal-title":"PloS One"},{"key":"34788_CR50","doi-asserted-by":"crossref","unstructured":"Inoue, T. & Tanaka, Y. Cross-Protection of hepatitis B vaccination among different genotypes. Vaccines. 8(3), (2020).","DOI":"10.3390\/vaccines8030456"},{"issue":"3","key":"34788_CR51","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3138\/canlivj-2023-0003","volume":"6","author":"C Fernandes da Silva","year":"2023","unstructured":"Fernandes da Silva, C., Keeshan, A. & Cooper, C. Hepatitis B virus genotypes influence clinical outcomes: A review. Can. Liver J. 6 (3), 347\u2013352 (2023).","journal-title":"Can. Liver J."},{"key":"34788_CR52","doi-asserted-by":"publisher","first-page":"903685","DOI":"10.3389\/fimmu.2022.903685","volume":"13","author":"J Peng","year":"2022","unstructured":"Peng, J. et al. The investigation of hepatitis B vaccine immune responses in occult hepatitis B Virus-Infected patients. Front. Immunol. 13, 903685 (2022).","journal-title":"Front. Immunol."},{"issue":"31","key":"34788_CR53","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.3748\/wjg.v28.i31.4249","volume":"28","author":"FA Di Lello","year":"2022","unstructured":"Di Lello, F. A., Mart\u00ednez, A. P. & Flichman, D. M. Insights into induction of the immune response by the hepatitis B vaccine. World J. Gastroenterol. 28 (31), 4249\u20134262 (2022).","journal-title":"World J. Gastroenterol."},{"key":"34788_CR54","unstructured":"foundation HB. https:\/\/www.hepb.org\/blog\/growing-older-with-hepatitis-b-why-testing-for-liver-damage-still-matters, accessed on 7\/12\/2025."},{"key":"34788_CR55","doi-asserted-by":"publisher","first-page":"1211980","DOI":"10.3389\/fimmu.2023.1211980","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu, X., Chen, S. X., Liu, H. & Lou, J. L. Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients. Front. Immunol. 14, 1211980 (2023).","journal-title":"Front. Immunol."},{"key":"34788_CR56","doi-asserted-by":"crossref","unstructured":"Ortega-Prieto, A. M. & Dorner, M. Immune evasion strategies during chronic hepatitis B and C virus infection. Vaccines. 5 (3) (2017).","DOI":"10.3390\/vaccines5030024"},{"issue":"13","key":"34788_CR57","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3748\/wjg.v22.i13.3531","volume":"22","author":"HL Zhu","year":"2016","unstructured":"Zhu, H. L., Li, X., Li, J. & Zhang, Z. H. Genetic variation of occult hepatitis B virus infection. World J. Gastroenterol. 22 (13), 3531\u20133546 (2016).","journal-title":"World J. Gastroenterol."},{"key":"34788_CR58","doi-asserted-by":"crossref","unstructured":"Nuermaimaiti, A. & Chang, L. The role of sex hormones and receptors in HBV infection and development of HBV-related HCC. J. Med. Virol. 95 (12), e29298 (2023).","DOI":"10.1002\/jmv.29298"},{"key":"34788_CR59","doi-asserted-by":"crossref","unstructured":"Park, E. S. & Won, J. Gender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection. Antiviral Res. 28 (1), 466\u2013480 (2024).","DOI":"10.1080\/19768354.2024.2403569"},{"key":"34788_CR60","doi-asserted-by":"publisher","first-page":"698121","DOI":"10.3389\/fimmu.2021.698121","volume":"12","author":"L Gay","year":"2021","unstructured":"Gay, L. et al. Sexual dimorphism and gender in infectious diseases. Front. Immunol. 12, 698121 (2021).","journal-title":"Front. Immunol."},{"key":"34788_CR61","doi-asserted-by":"crossref","unstructured":"Brown, R., Goulder, P. & Matthews, P. C. Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts. 7:32 (2022).","DOI":"10.12688\/wellcomeopenres.17601.1"},{"issue":"4","key":"34788_CR62","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1128\/JVI.06707-11","volume":"86","author":"Y Tian","year":"2012","unstructured":"Tian, Y., Kuo, C. F., Chen, W. L. & Ou, J. H. Enhancement of hepatitis B virus replication by androgen and its receptor in mice. J. Virol. 86 (4), 1904\u20131910 (2012).","journal-title":"J. Virol."},{"key":"34788_CR63","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.3389\/fimmu.2018.02302","volume":"9","author":"A Ruggieri","year":"2018","unstructured":"Ruggieri, A., Gagliardi, M. C. & Anticoli, S. Sex-Dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses? Front. Immunol. 9, 2302 (2018).","journal-title":"Front. Immunol."},{"issue":"32","key":"34788_CR64","doi-asserted-by":"publisher","first-page":"32ra35","DOI":"10.1126\/scitranslmed.3001143","volume":"2","author":"MH Wu","year":"2010","unstructured":"Wu, M. H. et al. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci. Transl. Med. 2 (32), 32ra35 (2010).","journal-title":"Sci. Transl. Med."},{"issue":"20","key":"34788_CR65","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.3748\/wjg.v20.i20.6252","volume":"20","author":"WC Liu","year":"2014","unstructured":"Liu, W. C. & Liu, Q. Y. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J. Gastroenterol. 20 (20), 6252\u20136261 (2014).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"34788_CR66","doi-asserted-by":"publisher","first-page":"110519","DOI":"10.1016\/j.isci.2024.110519","volume":"27","author":"J Zhao","year":"2024","unstructured":"Zhao, J. et al. Androgen receptor-induced molecules and androgen contribute synergistically to male-predominance of hepatocellular carcinoma. iScience 27 (8), 110519 (2024).","journal-title":"iScience"},{"issue":"2","key":"34788_CR67","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.virol.2007.01.040","volume":"363","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y., Chen, W. L., Ma, W. L., Chang, C. & Ou, J. H. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363 (2), 454\u2013461 (2007).","journal-title":"Virology"},{"key":"34788_CR68","doi-asserted-by":"publisher","first-page":"1342862","DOI":"10.3389\/fmicb.2024.1342862","volume":"15","author":"M Anderson","year":"2024","unstructured":"Anderson, M. et al. Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-na\u00efve people living with HIV in Botswana. Front. Microbiol. 15, 1342862 (2024).","journal-title":"Front. Microbiol."},{"issue":"1","key":"34788_CR69","doi-asserted-by":"publisher","first-page":"19845","DOI":"10.1038\/s41598-023-45672-5","volume":"13","author":"J Li","year":"2023","unstructured":"Li, J., Xu, Z. & Zhu, H. Spatial-temporal analysis and Spatial drivers of hepatitis-related deaths in 183 countries, 2000\u20132019. Sci. Rep. 13 (1), 19845 (2023).","journal-title":"Sci. Rep."},{"issue":"33","key":"34788_CR70","doi-asserted-by":"publisher","first-page":"10052","DOI":"10.12998\/wjcc.v9.i33.10052","volume":"9","author":"HQ Xu","year":"2021","unstructured":"Xu, H. Q., Wang, C. G., Zhou, Q. & Gao, Y. H. Effects of alcohol consumption on viral hepatitis B and C. World J. Clin. Cases. 9 (33), 10052\u201310063 (2021).","journal-title":"World J. Clin. Cases"},{"issue":"15","key":"34788_CR71","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3748\/wjg.v23.i15.2651","volume":"23","author":"A Iida-Ueno","year":"2017","unstructured":"Iida-Ueno, A., Enomoto, M., Tamori, A. & Kawada, N. Hepatitis B virus infection and alcohol consumption. World J. Gastroenterol. 23 (15), 2651\u20132659 (2017).","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"34788_CR72","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3748\/wjg.v26.i9.883","volume":"26","author":"M Ganesan","year":"2020","unstructured":"Ganesan, M., Eikenberry, A., Poluektova, L. Y., Kharbanda, K. K. & Osna, N. A. Role of alcohol in pathogenesis of hepatitis B virus infection. World J. Gastroenterol. 26 (9), 883\u2013903 (2020).","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"34788_CR73","first-page":"e56923","volume":"16","author":"J Tharmalingam","year":"2024","unstructured":"Tharmalingam, J., Gangadaran, P., Rajendran, R. L. & Ahn, B. C. Impact of alcohol on Inflammation, Immunity, Infections, and extracellular vesicles in pathogenesis. Cureus 16 (3), e56923 (2024).","journal-title":"Cureus"},{"issue":"1","key":"34788_CR74","doi-asserted-by":"publisher","first-page":"27251","DOI":"10.1038\/srep27251","volume":"6","author":"S Yang","year":"2016","unstructured":"Yang, S. et al. Factors influencing Immunologic response to hepatitis B vaccine in adults. Sci. Rep. 6 (1), 27251 (2016).","journal-title":"Sci. Rep."},{"issue":"2","key":"34788_CR75","doi-asserted-by":"publisher","first-page":"185","DOI":"10.35946\/arcr.v37.2.04","volume":"37","author":"S Pasala","year":"2015","unstructured":"Pasala, S., Barr, T. & Messaoudi, I. Impact of alcohol abuse on the adaptive immune system. Alcohol Research: Curr. Reviews. 37 (2), 185\u2013197 (2015).","journal-title":"Alcohol Research: Curr. Reviews"},{"issue":"4","key":"34788_CR76","first-page":"228","volume":"2","author":"S Gitto","year":"2014","unstructured":"Gitto, S., Vitale, G., Villa, E. & Andreone, P. Update on alcohol and viral hepatitis. J. Clin. Translational Hepatol. 2 (4), 228\u2013233 (2014).","journal-title":"J. Clin. Translational Hepatol."},{"key":"34788_CR77","doi-asserted-by":"crossref","unstructured":"Tahir, A., Shinkafi, S. H. & Alshrari, A. S. A comprehensive review of hepatitis B vaccine nonresponse and associated risk factors. Vaccines 12(7) (2024).","DOI":"10.3390\/vaccines12070710"},{"key":"34788_CR78","doi-asserted-by":"crossref","unstructured":"Zhang, M. & Mouzannar, K. Hepatitis B virus genotypes A1 and A2 have distinct replication phenotypes due to polymorphisms in the HBx gene. PLoS Pathogens 21(1), e1012803 (2025).","DOI":"10.1371\/journal.ppat.1012803"},{"key":"34788_CR79","doi-asserted-by":"publisher","first-page":"872766","DOI":"10.3389\/fmicb.2022.872766","volume":"13","author":"NM Araujo","year":"2022","unstructured":"Araujo, N. M. & Osiowy, C. Hepatitis B virus genotype G: the odd cousin of the family. Front. Microbiol. 13, 872766 (2022).","journal-title":"Front. Microbiol."},{"key":"34788_CR80","doi-asserted-by":"crossref","unstructured":"Adel Dawood, A. Hepatitis B Virus, Genotypes and Subtypes. In: Hepatitis B. edn. Edited by Rodrigo L. London: IntechOpen; (2022).","DOI":"10.5772\/intechopen.100446"},{"issue":"4","key":"34788_CR81","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3138\/canlivj-2019-0031","volume":"3","author":"V Meier-Stephenson","year":"2020","unstructured":"Meier-Stephenson, V. et al. Prevalence and molecular characterization of occult hepatitis B virus in pregnant women from Gondar, Ethiopia. Can. Liver J. 3 (4), 323\u2013333 (2020).","journal-title":"Can. Liver J."},{"issue":"2","key":"34788_CR82","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.5493\/wjem.v15.i2.102395","volume":"15","author":"MM Ratnaparkhi","year":"2025","unstructured":"Ratnaparkhi, M. M., Vyawahare, C. R. & Gandham, N. R. Hepatitis B virus genotype distribution and mutation patterns: insights and clinical implications for hepatitis B virus positive patients. World J. Experimental Med. 15 (2), 102395 (2025).","journal-title":"World J. Experimental Med."},{"issue":"10","key":"34788_CR83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/01.NAJ.0000794280.73744.fe","volume":"121","author":"B Capili","year":"2021","unstructured":"Capili, B. Cross-Sectional studies. Am. J. Nurs. 121 (10), 59\u201362 (2021).","journal-title":"Am. J. Nurs."},{"key":"34788_CR84","unstructured":"NumberAnalytics: https:\/\/www.numberanalytics.com\/blog\/ultimate-guide-cross-sectional-study-infectious-disease-epidemiology, accessed on 8\/23\/2025."},{"key":"34788_CR85","doi-asserted-by":"crossref","unstructured":"Sanchez, T. R., Inostroza-Nieves, Y., Hemal, K. & Chen, W. Chap. 37 - Cross-sectional study: design, measures, classic examples. In: Translational Surgery. edn. Edited by Eltorai AEM, Bakal JA, Newell PC, Osband AJ: Academic Press; 219\u2013222 (2023).","DOI":"10.1016\/B978-0-323-90300-4.00030-6"},{"issue":"1, Supplement","key":"34788_CR86","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.chest.2020.03.012","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang, X. & Cheng, Z. Cross-Sectional studies: Strengths, Weaknesses, and recommendations. Chest 158 (1, Supplement), S65\u2013S71 (2020).","journal-title":"Chest"},{"key":"34788_CR87","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Guerrero, E. E. & Guill\u00e9n-Medina, M. R. Methodological and statistical considerations for Cross-Sectional. Case-Control Cohort Stud. 13(14), (2024).","DOI":"10.3390\/jcm13144005"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34788-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34788-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T11:03:07Z","timestamp":1770116587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34788-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34788"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34788-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institutional Research Ethics Review Committee (IRERC) of the College of Health Sciences at Debre Markos University approved the study, which was conducted in accordance with the Declaration of Helsinki. The protocol number for this approval is [R\/C\/S\/D\/317\/01\/16].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"4701"}}